In a press release on Thursday morning, Danish biotech company Bavarian Nordic states that new preclinical trial data indicates that the firm's vaccine candidate against covid-19 also has the ability to induce a high number of neutralizing antibodies against covid variants and mutations.
"We are pleased to confirm the strong antibody response against emerging and more concerning variants of Sars-CoV2 for our covid-19 vaccine candidate," says Bavarian Nordic CEO Paul Chaplin the statement.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Lundbeck chairman demands change: "We can't live with this"
Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.
Coloplast could win big on Polish reimbursement changes
The Polish Ministry of Health has increased the reimbursement amount for hydrophilic catheters, which Coloplast supplies. The Danish medtech company calls the new scheme a "breakthrough."
Several positive elements in Eli Lilly Q3 report, says analyst
.jpg)
An analyst at Sydbank thinks that Eli Lilly's third quarter report includes a number of positive elements, and emphasizes that this could also be good news for competitor Novo Nordisk.
Eli Lilly upgrades earnings per share guidance
On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.
Cloud computing saves money and cuts carbon emissions at Novo Nordisk
Integrating cloud solutions has helped with Novo Nordisk's sustainable transition, Danish media reports.
Regulatory Science Specialist 
QA Specialist wanted 
Senior Training and Learning Expert – Help us build a best-in-class global learning and quality culture 
CMC Product Support Manager 
Clinical Business Process Manager 
Senior Validation Analyst, Zealand Pharma 
Jr. Software Developer, Cardiac Applications – Medical Devices, DK 
Senior Manager/Associate Director Regulatory Affairs 
Associate Director – MedTech Manufacturing 
Director of Biostatistics 
Clinical Documentation Specialist 
Principal Statistician / Statistical Project Director 
Nordic Field Sales Manager 
Senior Clinical Trial Manager